Juliane Bolbrinker

7PUBLICATIONS
17CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)GravimetricsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2026
UMOD Genotype and Clinical Outcomes in Heart Failure Patients Treated with Loop Diuretics: A UK Biobank Pharmacogenetic Cohort Study.

|Jan 30, 2023
Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E2 Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and Albuminuria.

Aikaterini Kourpa, Angela Schulz, Eva Mangelsen

|Nov 28, 2022
Longitudinal effects of a common UMOD variant on kidney function, blood pressure, cognitive and physical function in older women and men.

Engi Abdel-Hady Algharably, Linda Elizabeth Villagomez Fuentes, Sarah Toepfer

|Oct 01, 2021
Effect of a common UMOD variant on kidney function, blood pressure, cognitive and physical function in a community-based cohort of older adults.

Linda Elizabeth Villagomez Fuentes, Engi Abdel-Hady Algharably, Sarah Toepfer

|May 23, 2020
Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E2 Activation in Human Podocytes.

Eva Mangelsen, Michael Rothe, Angela Schulz

|May 26, 2017
Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Juliane Bolbrinker, Edeltraut Garbe, Antonios Douros

Pageof 2

Frequent Collaborators

2 joint publications

Eva Mangelsen

2 joint publications

Linda Elizabeth Villagomez Fuentes

2 joint publications

Ilja Demuth

2 joint publications

Reinhold Kreutz